Logo image of ETAO

ETAO INTERNATIONAL CO LTD (ETAO) Stock Fundamental Analysis

NASDAQ:ETAO - Nasdaq - KYG313631155 - Common Stock - Currency: USD

1.91  -0.89 (-31.79%)

After market: 1.25 -0.66 (-34.55%)

Fundamental Rating

1

Taking everything into account, ETAO scores 1 out of 10 in our fundamental rating. ETAO was compared to 102 industry peers in the Health Care Providers & Services industry. ETAO may be in some trouble as it scores bad on both profitability and health. ETAO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ETAO has reported negative net income.
In the past year ETAO had a positive cash flow from operations.
ETAO Yearly Net Income VS EBIT VS OCF VS FCFETAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 -200M -400M -600M -800M

1.2 Ratios

ETAO has a Return On Assets of -1692.57%. This is amonst the worse of the industry: ETAO underperforms 98.29% of its industry peers.
Industry RankSector Rank
ROA -1692.57%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ETAO Yearly ROA, ROE, ROICETAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2K -2K 4K

1.3 Margins

ETAO's Gross Margin of 32.72% is in line compared to the rest of the industry. ETAO outperforms 57.27% of its industry peers.
The Profit Margin and Operating Margin are not available for ETAO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ETAO Yearly Profit, Operating, Gross MarginsETAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 0 -500 -1K -1.5K

2

2. Health

2.1 Basic Checks

ETAO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ETAO has more shares outstanding
Compared to 1 year ago, ETAO has a worse debt to assets ratio.
ETAO Yearly Shares OutstandingETAO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 20M 40M 60M 80M 100M
ETAO Yearly Total Debt VS Total AssetsETAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -68.91, we must say that ETAO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -68.91, ETAO is not doing good in the industry: 91.45% of the companies in the same industry are doing better.
ETAO has a debt to FCF ratio of 0.97. This is a very positive value and a sign of high solvency as it would only need 0.97 years to pay back of all of its debts.
ETAO's Debt to FCF ratio of 0.97 is amongst the best of the industry. ETAO outperforms 90.60% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0.97
Altman-Z -68.91
ROIC/WACCN/A
WACC8.55%
ETAO Yearly LT Debt VS Equity VS FCFETAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 20M 40M

2.3 Liquidity

ETAO has a Current Ratio of 0.77. This is a bad value and indicates that ETAO is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ETAO (0.77) is worse than 81.20% of its industry peers.
A Quick Ratio of 0.71 indicates that ETAO may have some problems paying its short term obligations.
ETAO has a worse Quick ratio (0.71) than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.71
ETAO Yearly Current Assets VS Current LiabilitesETAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 10M 20M 30M 40M 50M

0

3. Growth

3.1 Past

The earnings per share for ETAO have decreased strongly by -4967.76% in the last year.
EPS 1Y (TTM)-4967.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5999.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ETAO Yearly Revenue VS EstimatesETAO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 10M 20M 30M 40M 50M

2

4. Valuation

4.1 Price/Earnings Ratio

ETAO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ETAO Price Earnings VS Forward Price EarningsETAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than ETAO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.96
EV/EBITDA N/A
ETAO Per share dataETAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ETAO!.
Industry RankSector Rank
Dividend Yield N/A

ETAO INTERNATIONAL CO LTD

NASDAQ:ETAO (5/8/2024, 8:00:01 PM)

After market: 1.25 -0.66 (-34.55%)

1.91

-0.89 (-31.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.2%
Inst Owner Change-75.29%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.78M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF 0.96
P/OCF 0.9
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.99
FCFY104.2%
OCF(TTM)2.11
OCFY110.68%
SpS11.34
BVpS-3.05
TBVpS-3.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1692.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.72%
FCFM 17.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0.97
Debt/EBITDA N/A
Cap/Depr 32.48%
Cap/Sales 1.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.71
Altman-Z -68.91
F-Score4
WACC8.55%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4967.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5999.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-220440%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4139%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4390.26%
OCF growth 3YN/A
OCF growth 5YN/A